Should You Buy NuScale Power While It's Below $12?

NuScale finished 2025 with $1.3B in cash and investments but reported only $31.5M in revenue last year and its stock is down >37% over the past year. The company holds the only NRC‑approved SMR design with 788 patents and 12 modules in production, yet it has no commercial reactors deployed, making it a high‑risk, long‑duration exposure despite Morgan Stanley’s $2.2T nuclear investment outlook through 2050.

Analysis

NuScale’s story is a classic FOAK-technology-on-a-balance-sheet problem: the economic value lies in a long-dated option on modular reactors and in near-term licensing/engineering services. The immediate industrial winners are unlikely to be the reactor OEM alone but the firms that scale modular fabrication yards, heavy forgings, control-system integrators, and logistics providers — these nodes capture cash early and de-risk execution before merchant power revenues flow.

Execution risk is concentrated in a narrow window: the next 24–36 months determine whether learning curves and supply chains compress unit capex materially or whether projects remain bespoke and capital-starved. A sustained 100 bps move higher in real yields or a single high-profile construction delay could widen the LCOE gap vs gas/renewables by several percentage points and push revenue realization out by 3–7 years.

The market consensus is binary—either full-scale SMR roll-out or permanent irrelevance—so asymmetric option positions dominate the efficient trade set. Meanwhile, AI-driven load growth creates durable demand for dispatchable capacity; that tailwind disproportionately helps companies that bridge the gap quickly (financial sponsors, EPCs, and data-center hyperscalers hedging power risk), not necessarily the FOAK OEM.

Put another way: value is more likely to be crystallized through licensing, service contracts, or infrastructure finance fees than through merchant power sales from Naïve equity ownership today. That argues for trade structures that monetize near-term optionality and mortgage long-dated policy/scale outcomes to counterparties better able to build factories and raise project finance.

Key Decisions for Investors

• Short SMR equity or buy 9–12 month put protection (SMR) to capture FOAK execution risk — position size 1–2% notional. R/R: limited loss = option premium; reward if a constructive catalyst fails (project delay, permit denial) should exceed 3:1 if stock re-rates to pure-services multiple.
• Pair trade: Long Morgan Stanley (MS) common or 12–18 month call spread vs short SMR equity. Thesis: MS captures advisory/financing fees as projects move to FID; expect 12–18 month upside if modular projects reach binding EPC/loan mandates. Risk: MS is market-sensitive; hedge 50% beta with S&P futures.
• Buy a defined-cost bullish exposure to AI beneficiaries (NVDA) via a 6–9 month call spread to express durable compute-driven power demand (NVDA). R/R: limited premium with asymmetric upside if hyperscaler capex accelerates; use as a hedge to energy-technology idiosyncratic short positions.
• Small speculative long on INTC long-dated calls (18–24 months) sized 0.5–1% notional to capture any pivot where incumbents win control-system or silicon integration work for SMRs. R/R: high skew—small premium for optionality if industrial demand triggers strategic wins; max loss = premium.